Clinical Research Directory

Inclusion Criteria: * ◦ Patients with epithelial ovarian cancer, including high- and low-grade serous, high- and low-grade endometrioid, mucinous (expansile and infiltrative types), and carcinosarcoma. * FIGO 2014 stage IA-IVB. * Patients undergoing primary surgery or interval surgery after 3-4 or 6 cycles of chemtherapy * Patients with no residual disease after surgery. * Patients with ECOG performance status 0-1. Exclusion Criteria: * ◦ Patients without epithelial ovarian cancer. * Patients with ECOG 2-4. * Patients who do not consent to participate in the study. * Patients who did not undergo complete staging surgery (including hysterectomy, bilateral salpingo-oophorectomy, pelvic and para-aortic lymphadenectomy, and omentectomy) or with residual disease after cytoreductive surgery.